NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Property, Plant & Equipment (Net) (2021 - 2025)

NewcelX (NCEL) Property, Plant & Equipment (Net) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 NewcelX 12.54 Mn 10.34 Mn - 95,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 95,000.00
Dec 31, 2025 95,000.00
Jun 30, 2025 5,303.00
Jun 30, 2025 5,303.00
Dec 31, 2024 123,000.00
Dec 31, 2024 123,000.00
Jun 30, 2024 990.00
Jun 30, 2024 990.00
Dec 31, 2023 6,694.00
Dec 31, 2023 6,694.00
Jun 30, 2023 12,398.00
Jun 30, 2023 12,398.00
Dec 31, 2022 18,102.00
Dec 31, 2022 18,102.00
Jun 30, 2022 23,806.00
Jun 30, 2022 23,806.00
Dec 31, 2021 29,510.00
Dec 31, 2021 29,510.00
Jun 30, 2021 27,733.00
Jun 30, 2021 27,733.00